At first glance, low expression of PDCD4 in tumor cells would be expected to impede the cell cycle, however, many tumor cells have a defective G1/S checkpoint as a result of p53 or other mutations, neutralizing the inhibitory effects of low PDCD4 expression on the G1/S-transition. Here, TP53 is linked to neoplasm.